{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:39:03Z","timestamp":1791405543238,"version":"4.3.3"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Experimental autoimmune encephalomyelitis (EAE) is a T lymphocyte-mediated autoimmune disease of the CNS. Significant roles for B cells and a rare IL-10\u2013producing CD1dhighCD5+ regulatory B cell subset (B10 cells) have been identified during the initiation and progression of EAE. Whether and how the regulatory functions of B10 cells and FoxP3+ T regulatory cells (Tregs) overlap or influence EAE immunopathogenesis independently has remained unanswered. This study demonstrates that the number of endogenous or adoptively transferred B10 cells directly influenced EAE pathogenesis through their production of IL-10. B10 cell numbers expanded quickly within the spleen, but not CNS following myelin oligodendrocyte glycoprotein35\u201355 immunization, which paralleled B10 cell regulation of disease initiation. The adoptive transfer of myelin oligodendrocyte glycoprotein33\u201335-sensitized B10 cells into wild-type mice reduced EAE initiation dramatically. However, B10 cells did not suppress ongoing EAE disease. Rather, Treg numbers expanded significantly within the CNS during disease progression, which paralleled their negative regulation of late-phase disease. Likewise, the preferential depletion of B10 cells in vivo during disease initiation enhanced EAE pathogenesis, whereas Treg depletion enhanced late-phase disease. B10 cells did not regulate T cell proliferation during in vitro assays, but significantly altered CD4+ T cell IFN-\u03b3 and TNF-\u03b1 production. Furthermore, B10 cells downregulated the ability of dendritic cells to act as APCs and thereby indirectly modulated T cell proliferation. Thus, B10 cells predominantly control disease initiation, whereas Tregs reciprocally inhibit late-phase disease, with overlapping B10 cell and Treg functions shaping the normal course of EAE immunopathogenesis.<\/jats:p>","DOI":"10.4049\/jimmunol.1001307","type":"journal-article","created":{"date-parts":[[2010,7,12]],"date-time":"2010-07-12T19:43:36Z","timestamp":1278963816000},"page":"2240-2252","source":"Crossref","is-referenced-by-count":349,"title":["Regulatory B Cells (B10 Cells) and Regulatory T Cells Have Independent Roles in Controlling Experimental Autoimmune Encephalomyelitis Initiation and Late-Phase Immunopathogenesis"],"prefix":"10.1093","volume":"185","author":[{"given":"Takashi","family":"Matsushita","sequence":"first","affiliation":[{"name":"Department of Immunology, Duke University Medical Center , Durham, NC 27710"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuka","family":"Horikawa","sequence":"additional","affiliation":[{"name":"Department of Immunology, Duke University Medical Center , Durham, NC 27710"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Immunology, Duke University Medical Center , Durham, NC 27710"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F","family":"Tedder","sequence":"additional","affiliation":[{"name":"Department of Immunology, Duke University Medical Center , Durham, NC 27710"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,8,15]]},"reference":[{"key":"2025032411480501300_r1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10875-008-9236-x","article-title":"Multiple sclerosis and regulatory T cells","volume":"28","author":"Costantino","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"2025032411480501300_r2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2007.11.016","article-title":"Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease","volume":"193","author":"O\u2019Connor","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"2025032411480501300_r3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/intimm\/dxh029","article-title":"IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells","volume":"16","author":"Zhang","year":"2004","journal-title":"Int. Immunol."},{"key":"2025032411480501300_r4","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: how they develop and function","volume":"112","author":"LeBien","year":"2008","journal-title":"Blood"},{"key":"2025032411480501300_r5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-065X.2008.00646.x","article-title":"B-lymphocyte contributions to human autoimmune disease","volume":"223","author":"Yanaba","year":"2008","journal-title":"Immunol. Rev."},{"key":"2025032411480501300_r6","doi-asserted-by":"crossref","first-page":"20878","DOI":"10.1073\/pnas.0709205105","article-title":"Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice","volume":"104","author":"Bouaziz","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032411480501300_r7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.coi.2008.03.003","article-title":"Cytokine-producing B lymphocytes: key regulators of immunity","volume":"20","author":"Lund","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"2025032411480501300_r8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"2025032411480501300_r9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.21363","article-title":"Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial","volume":"63","author":"Bar-Or","year":"2008","journal-title":"Ann. Neurol."},{"key":"2025032411480501300_r10","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.184.6.2271","article-title":"Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice","volume":"184","author":"Wolf","year":"1996","journal-title":"J. Exp. Med."},{"key":"2025032411480501300_r11","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat. Immunol."},{"key":"2025032411480501300_r12","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J. Clin. Invest."},{"key":"2025032411480501300_r13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4049\/jimmunol.176.2.705","article-title":"A case for regulatory B cells","volume":"176","author":"Mizoguchi","year":"2006","journal-title":"J. Immunol."},{"key":"2025032411480501300_r14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.it.2005.11.003","article-title":"To \u2018B\u2019 regulated: B cells as members of the regulatory workforce","volume":"27","author":"Serra","year":"2006","journal-title":"Trends Immunol."},{"key":"2025032411480501300_r15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.it.2007.10.004","article-title":"The \u2018short\u2019 history of regulatory B cells","volume":"29","author":"Mauri","year":"2008","journal-title":"Trends Immunol."},{"key":"2025032411480501300_r16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-065X.2008.00661.x","article-title":"Regulatory B cells as inhibitors of immune responses and inflammation","volume":"224","author":"Bouaziz","year":"2008","journal-title":"Immunol. Rev."},{"key":"2025032411480501300_r17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"key":"2025032411480501300_r18","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.4049\/jimmunol.0902391","article-title":"Protective and pathogenic roles for B cells during systemic autoimmunity in NZB\/W F1 mice","volume":"184","author":"Haas","year":"2010","journal-title":"J. Immunol."},{"key":"2025032411480501300_r19","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.4049\/jimmunol.0902385","article-title":"Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity","volume":"184","author":"Watanabe","year":"2010","journal-title":"J. Immunol."},{"key":"2025032411480501300_r20","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.4049\/jimmunol.0901719","article-title":"CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions","volume":"184","author":"Nakashima","year":"2010","journal-title":"J. Immunol."},{"key":"2025032411480501300_r21","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.4049\/jimmunol.0900270","article-title":"The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals","volume":"182","author":"Yanaba","year":"2009","journal-title":"J. Immunol."},{"key":"2025032411480501300_r22","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.161.7.3299","article-title":"IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice","volume":"161","author":"Bettelli","year":"1998","journal-title":"J. Immunol."},{"key":"2025032411480501300_r23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0165-5728(92)90213-5","article-title":"Direct demonstration of the infiltration of murine central nervous system by Pgp-1\/CD44high CD45RBlow CD4+ T cells that induce experimental allergic encephalomyelitis","volume":"40","author":"Zeine","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"2025032411480501300_r24","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1084\/jem.20040119","article-title":"The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy","volume":"199","author":"Uchida","year":"2004","journal-title":"J. Exp. Med."},{"key":"2025032411480501300_r25","first-page":"3884","article-title":"Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development","volume":"14","author":"Zhou","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"2025032411480501300_r26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"K\u00fchn","year":"1993","journal-title":"Cell"},{"key":"2025032411480501300_r27","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.4049\/jimmunol.157.10.4371","article-title":"CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity","volume":"157","author":"Sato","year":"1996","journal-title":"J. Immunol."},{"key":"2025032411480501300_r28","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.158.10.4662","article-title":"CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19","volume":"158","author":"Sato","year":"1997","journal-title":"J. Immunol."},{"key":"2025032411480501300_r29","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.4049\/jimmunol.177.5.3063","article-title":"CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo","volume":"177","author":"Haas","year":"2006","journal-title":"J. Immunol."},{"key":"2025032411480501300_r30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/76957","article-title":"CCR5 provides a signal for microbial induced production of IL-12 by CD8 \u03b1+ dendritic cells","volume":"1","author":"Aliberti","year":"2000","journal-title":"Nat. Immunol."},{"key":"2025032411480501300_r31","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2353\/ajpath.2006.050923","article-title":"Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response","volume":"168","author":"Matsushita","year":"2006","journal-title":"Am. J. Pathol."},{"key":"2025032411480501300_r32","doi-asserted-by":"crossref","first-page":"15434","DOI":"10.1073\/pnas.0404444101","article-title":"Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis","volume":"101","author":"Reddy","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032411480501300_r33","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.4049\/jimmunol.175.5.3025","article-title":"Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system","volume":"175","author":"McGeachy","year":"2005","journal-title":"J. Immunol."},{"key":"2025032411480501300_r34","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm1402","article-title":"Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE","volume":"12","author":"Liu","year":"2006","journal-title":"Nat. Med."},{"key":"2025032411480501300_r35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1564","article-title":"Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation","volume":"13","author":"Korn","year":"2007","journal-title":"Nat. Med."},{"key":"2025032411480501300_r36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/cimm.1995.9976","article-title":"Suppression of immunopathology in schistosomiasis by interleukin-2-targeted fusion toxin, DAB389IL-2. I. Studies of in vitro and in vivo efficacy","volume":"166","author":"Ramadan","year":"1995","journal-title":"Cell. Immunol."},{"key":"2025032411480501300_r37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.177.1.84","article-title":"IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice","volume":"177","author":"Knutson","year":"2006","journal-title":"J. Immunol."},{"key":"2025032411480501300_r38","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1182\/blood-2007-06-094615","article-title":"IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity","volume":"110","author":"Litzinger","year":"2007","journal-title":"Blood"},{"key":"2025032411480501300_r39","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1084\/jem.20021603","article-title":"Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis","volume":"197","author":"Bettelli","year":"2003","journal-title":"J. Exp. Med."},{"key":"2025032411480501300_r40","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"2025032411480501300_r41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2007.05.032","article-title":"Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats","volume":"263","author":"Phillips","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"2025032411480501300_r42","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4049\/jimmunol.178.6.3447","article-title":"B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis","volume":"178","author":"Mann","year":"2007","journal-title":"J. Immunol."},{"key":"2025032411480501300_r43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.2009.05137.x","article-title":"B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer","volume":"1183","author":"DiLillo","year":"2010","journal-title":"Ann. NY Acad. Sci."},{"key":"2025032411480501300_r44","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.4049\/jimmunol.180.7.4763","article-title":"TLR-activated B cells suppress T cell-mediated autoimmunity","volume":"180","author":"Lampropoulou","year":"2008","journal-title":"J. Immunol."},{"key":"2025032411480501300_r45","doi-asserted-by":"crossref","first-page":"958","DOI":"10.4049\/jimmunol.179.2.958","article-title":"The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells","volume":"179","author":"O\u2019Connor","year":"2007","journal-title":"J. Immunol."},{"key":"2025032411480501300_r46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/pr.55.2.4","article-title":"Interleukin-10 therapy: review of a new approach","volume":"55","author":"Asadullah","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"2025032411480501300_r47","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J. Immunol."},{"key":"2025032411480501300_r48","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.190.7.995","article-title":"An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation","volume":"190","author":"Asseman","year":"1999","journal-title":"J. Exp. Med."},{"key":"2025032411480501300_r49","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.4049\/jimmunol.165.9.4848","article-title":"T regulatory cells 1 inhibit a Th2-specific response in vivo","volume":"165","author":"Cottrez","year":"2000","journal-title":"J. Immunol."},{"key":"2025032411480501300_r50","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/intimm\/2.9.821","article-title":"Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10","volume":"2","author":"O\u2019Garra","year":"1990","journal-title":"Int. Immunol."},{"key":"2025032411480501300_r51","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.1791","article-title":"Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis","volume":"10","author":"Murai","year":"2009","journal-title":"Nat. Immunol."},{"key":"2025032411480501300_r52","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ni1121","article-title":"CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms","volume":"5","author":"Poe","year":"2004","journal-title":"Nat. Immunol."},{"key":"2025032411480501300_r53","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood-2008-01-135319","article-title":"Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines","volume":"112","author":"Morse","year":"2008","journal-title":"Blood"},{"key":"2025032411480501300_r54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00063030-200923010-00001","article-title":"Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies","volume":"23","author":"Kreitman","year":"2009","journal-title":"BioDrugs"},{"key":"2025032411480501300_r55","first-page":"3260","article-title":"Paradox of B cell-targeted therapies","volume":"118","author":"Kurosaki","year":"2008","journal-title":"J. Clin. Invest."},{"key":"2025032411480501300_r56","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1002\/art.22811","article-title":"Development of psoriasis after B cell depletion with rituximab","volume":"56","author":"Dass","year":"2007","journal-title":"Arthritis Rheum."},{"key":"2025032411480501300_r57","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/ibd.20215","article-title":"Exacerbation of ulcerative colitis after rituximab salvage therapy","volume":"13","author":"Goetz","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"2025032411480501300_r58","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archneur.64.10.1531","article-title":"Relapses after treatment with rituximab in a patient with multiple sclerosis and anti myelin-associated glycoprotein polyneuropathy","volume":"64","author":"Benedetti","year":"2007","journal-title":"Arch. Neurol."},{"key":"2025032411480501300_r59","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.4049\/jimmunol.179.11.7225","article-title":"Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner","volume":"179","author":"Hussain","year":"2007","journal-title":"J. Immunol."},{"key":"2025032411480501300_r60","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.178.12.7868","article-title":"Novel suppressive function of transitional 2 B cells in experimental arthritis","volume":"178","author":"Evans","year":"2007","journal-title":"J. Immunol."},{"key":"2025032411480501300_r61","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.4049\/jimmunol.178.10.6092","article-title":"Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis","volume":"178","author":"Duddy","year":"2007","journal-title":"J. Immunol."},{"key":"2025032411480501300_r62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ana.21438","article-title":"Helminth infections associated with multiple sclerosis induce regulatory B cells","volume":"64","author":"Correale","year":"2008","journal-title":"Ann. Neurol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/185\/4\/2240\/61610817\/1001307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/185\/4\/2240\/61610817\/1001307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T23:13:12Z","timestamp":1743203592000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/185\/4\/2240\/7977684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1001307","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,8]]},"published":{"date-parts":[[2010,8]]}}}